KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Assets (2016 - 2025)

Historic Assets for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $3.4 billion.

  • Idexx Laboratories' Assets rose 107.28% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year increase of 107.28%. This contributed to the annual value of $3.3 billion for FY2024, which is 102.82% up from last year.
  • Idexx Laboratories' Assets amounted to $3.4 billion in Q3 2025, which was up 107.28% from $3.3 billion recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Assets registered a high of $3.4 billion during Q2 2024, and its lowest value of $2.3 billion during Q1 2021.
  • Its 5-year average for Assets is $2.9 billion, with a median of $2.9 billion in 2023.
  • Its Assets has fluctuated over the past 5 years, first skyrocketed by 2338.72% in 2021, then tumbled by 416.95% in 2025.
  • Idexx Laboratories' Assets (Quarter) stood at $2.4 billion in 2021, then increased by 12.7% to $2.7 billion in 2022, then grew by 18.68% to $3.3 billion in 2023, then increased by 1.03% to $3.3 billion in 2024, then increased by 2.83% to $3.4 billion in 2025.
  • Its Assets was $3.4 billion in Q3 2025, compared to $3.3 billion in Q2 2025 and $3.2 billion in Q1 2025.